Neuralink Expected to Begin Human Clinical Trials in Six Months
By H.JanGra
www.lifeactive.in
Neuralink
Elon Musk said a wireless device developed by his brain chip company Neuralink is expected to begin human clinical trials in six months.
Neuralink
The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate again
Neuralink
Neuralink has in recent years been conducting tests on animals as it seeks US regulatory approval to begin clinical trials in people.
Neuralink
The event was originally planned for October 31 but Musk postponed it just days before without giving a reason.
Neuralink
Neuralink's last public presentation, more than a year ago, involved a monkey with a brain chip that played a computer game by thinking alone.
Neuralink
Musk said in a 2019 presentation he was aiming to receive regulatory approval by the end of 2020. He then said at a conference in late 2021 that he hoped to start human trials this year.
Neuralink
Neuralink has repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials, current and former employees have said
Neuralink
Musk approached competitor Synchron earlier this year about a potential investment after he expressed frustration to Neuralink employees about their slow progress
Neuralink
Synchron crossed a major milestone in July by implanting its device in a patient in the United States for the first time.
Neuralink
It received US regulatory clearance for human trials in 2021 and has completed studies in four people in Australia